Check-Cap appointed William Densel as CEO
16 August, 2015
Densel succeeds Guy Neev, who held the role of Chief Executive Officer since the Company's inception, for more than seven years
Densel succeeds Guy Neev, who held the role of Chief Executive Officer since the Company’s inception, for more than seven years
Check-Cap Ltd from from Isfiya, Israel, has appointed William (Bill) Densel as Chief Executive Officer. Check-Cap is a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening.
Densel joined Check-Cap earlier this year as President of U.S. Operations. He succeeds Guy Neev, who held the role of Chief Executive Officer since the Company’s inception, for more than seven years. Mr. Neev will serve as a consultant to the Company through the end of 2015.
Tomer Kariv, Chairman of the Board of Directors of Check-Cap stated: “As we prepare to execute on near and long-term corporate and clinical milestones, including a CE mark application and the commencement of an FDA pivotal study next year, our Board of Directors and management team believes that Bill’s experience and track record will enable us to effectively and efficiently realize our clinical, regulatory and reimbursement goals.”
Densel brings 25 years of leadership experience, including his most recent role as Chief Executive Officer of Beacon Endoscopic, Inc., a company specializing in advanced endoscopy devices, which was acquired by Covidien.
Check-Cap is a clinical stage medical diagnostics company focused on the development of innovative imaging devices. The Company is developing an ingestible capsule for the identification of colorectal cancer and pre-cancerous lesions in the colon.
Utilizing ultra-low-energy X-ray-based technology, the capsule safely generates high-resolution, 3-dimensional imagery of the interior of the colon. The Check-Cap imaging system is not cleared for marketing in any jurisdiction.